bioMerieux Executive and Leadership Team

Pearl Ngobeni, the Chief Financial Officer at bioMerieux, directs global financial strategy and operations. Ngobeni oversees all aspects of financial planning, accounting, and reporting, ensuring fiscal health and driving profitable growth. This leadership role involves managing capital allocation, optimizing resource deployment, and maintaining strong relationships with investors and financial institutions. By analyzing market trends and economic conditions, Ngobeni guides strategic financial decisions that support bioMerieux's expansion in in vitro diagnostics. The Chief Financial Officer ensures compliance with all financial regulations and implements robust internal controls to safeguard company assets. Ngobeni's oversight extends to managing currency risks and optimizing the company's tax structure across its international operations. This critical function underpins bioMerieux's ability to develop and manufacture innovative solutions for detecting infectious diseases and cancer worldwide.

Jana Inman, the Chief Financial Officer, Global Research & Development at bioMerieux, spearheads financial oversight for all research and development initiatives. Inman manages the budgeting, forecasting, and financial analysis specific to the company's innovation pipeline, ensuring R&D investments align with strategic objectives. This role involves close collaboration with scientific and product development teams to assess the financial viability of new diagnostic technologies and drug discovery programs. By optimizing R&D expenditures, Inman supports bioMerieux's commitment to developing cutting-edge solutions for detecting infectious diseases, cancer, and other health conditions. The Chief Financial Officer, Global Research & Development also monitors project-specific funding, tracks return on investment for research activities, and ensures efficient allocation of resources across global R&D centers. Jana Inman's financial acumen is vital for advancing bioMerieux's mission to provide innovative tools for clinical laboratories and healthcare professionals.

Pedro Soares, the Head Chief Financial Officer, Finance Brasil at bioMerieux, leads all financial operations and strategic planning within the Brazilian market. Soares manages financial reporting, budgeting, and forecasting, ensuring fiscal discipline and driving financial performance for bioMerieux's operations in Brazil. This role involves close collaboration with regional leadership to identify growth opportunities and mitigate financial risks specific to the local economic landscape. By overseeing treasury functions and optimizing capital structure, Soares supports the company's expansion of in vitro diagnostic solutions in Brasil. The Head Chief Financial Officer, Finance Brasil also ensures compliance with local financial regulations and tax laws, maintaining robust internal controls. Pedro Soares's financial expertise is essential for strengthening bioMerieux's presence and delivering innovative diagnostic tools to healthcare professionals and industrial clients throughout Brasil.

Jessica Weidner, the Clinical Operations, Chief of Staff (North America) at bioMerieux, directs strategic initiatives and operational efficiency within North American clinical operations. Weidner coordinates cross-functional teams to enhance the delivery of bioMerieux's diagnostic solutions, ensuring seamless integration of instruments, reagents, and services for clients. This leadership position involves optimizing clinical workflows, managing project portfolios, and driving process improvements that support the detection of infectious diseases and cancer. By fostering collaboration between clinical laboratories and healthcare professionals, Weidner ensures that bioMerieux's offerings meet the evolving needs of the North American market. The Clinical Operations, Chief of Staff (North America) also plays a key part in aligning operational strategies with the company's broader business objectives, focusing on service excellence and client satisfaction. Jessica Weidner's role is crucial for expanding bioMerieux's impact and supporting healthcare providers across the region.

Charles Cooper, the Executive VP & Chief Marketing Officer at bioMerieux, directs global marketing strategies and brand development. Cooper oversees the creation and execution of comprehensive marketing campaigns that highlight bioMerieux's innovative solutions for detecting infectious diseases, cancer, and other health conditions. This leadership role involves driving market penetration, enhancing brand visibility, and fostering strong relationships with clinical laboratories, healthcare professionals, and industrial clients worldwide. By analyzing market dynamics and customer needs, Cooper shapes product positioning and go-to-market strategies that support revenue growth and expand bioMerieux's global reach. The Executive VP & Chief Marketing Officer also leads market intelligence efforts, identifying emerging trends and competitive landscapes to inform strategic decision-making. Charles Cooper's marketing leadership is instrumental in communicating the value of bioMerieux's instruments, reagents, software, and services to a diverse international audience.